Aligos Therapeutics, Inc Earning Date (ALGS)

USA |NASDAQ |USD

ALGS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 21, 2022 Dec 2021 $-0.83 $-0.78 $-1.09
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 21, 2022 Dec 2021 $0.00 $1.54M $-10.55M

Aligos Therapeutics, Inc's next earnings date is Monday, Mar 21, 2022 for the fiscal quarter ending Dec 2021.

ALGS Earnings Date & History Chart

ALGS Earnings & Revenue Forecast

ALGS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 2 $-0.82 $-0.84 $-0.80
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $-3.45 $-4.12 $-3.16

ALGS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $-0.82 $-0.83 $-0.83
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-3.45 $-3.19 $-3.19

ALGS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 2 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $0.00 $0.00 $0.00

ALGS Earnings Date & Revenue History

ALGS Earnings History

|
Show More
Show More

ALGS Revenue History

|
Show More
Show More

Aligos Therapeutics, Inc Next Earnings Date & Report

ALGS Next Earnings Date & Report Preview: Dec 2021 (FQ)

ALGS's next earnings date is Monday, Mar 21, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 5 analysts, the average EPS estimation for Aligos Therapeutics, Inc's next quarterly earnings is $-0.83, with a low EPS estimation of $-0.88, and a high estimation of $-0.77.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.83, the last 2 month trend is $-0.80, and the 3 month trend is $-0.80.

Based on 5 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Aligos Therapeutics, Inc Previous Earnings Dates & Reports

ALGS Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Aligos Therapeutics, Inc's previous earnings date was Nov 4, 2021 for its fiscal quarter ended Sep 30, 2021.

ALGS's earnings per share (EPS) was $-0.78, beating the consensus analysts forecast of $-0.81 by 4.27%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -1.27%, and higher than the same period a year before (Sep 2020) by -10.70%.

Revenues were $1.54M.

The company reported a net income of $-33.12M.

Free cash flow for the quarter was $-25.46M , compared to $-23.17M last quarter and $-16.91M a year before.

ALGS ended the quarter with $12.42M in total debt, a decrease of -0.85% compared to the previous quarter, and a decrease of -6.93% compared to the same quarter a year before.

ALGS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aligos Therapeutics, Inc's previous annual earnings date was Mar 23, 2021 for its fiscal year ended Dec 31, 2020.

ALGS's earnings per share (EPS) was $-1.96.

Revenues were $-10.55M.

The company reported a net income of $-108.54M.

Aligos Therapeutics, Inc reported a free cash flow of $-76.33M for its fiscal year, compared to $-49.55M a year ago.

The company ended the fiscal year with $13.01M in total debt, a decrease of -9.24% compared to the previous year.